Home > Press > NVE Corporation Reports Third Quarter Results and Announces Stock Repurchase Program
Abstract:
NVE Corporation (Nasdaq:NVEC) announced today financial results for the quarter and nine months ended December 31, 2008.
Total revenue for the third quarter of fiscal 2009 increased 23% to $5.88 million from $4.77 million in the prior-year quarter. The revenue increase was due to an 8% increase in product sales and a 150% increase in contract research and development revenue. Net income for the third quarter of fiscal 2009 increased 45% to $2.47 million, or $0.52 per diluted share, compared to $1.70 million, or $0.36 per diluted share, for the prior-year quarter.
For the first nine months of fiscal 2009, total revenue increased 14% to $16.5 million from $14.5 million for the first nine months of fiscal 2008. The revenue increase for the first nine months of fiscal 2009 was due to a 9% increase in product sales and a 49% increase in contract research and development revenue. Net income for the first nine months of fiscal 2009 was $6.67 million, or $1.40 per diluted share compared to $4.93 million, or $1.04 per diluted share, for the first nine months of fiscal 2008.
"Despite a challenging economic environment, increases in product sales and contract research and development revenue drove record net income in the third quarter," said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D.
The company also announced today that its Board of Directors authorized the repurchase of up to $2.5 million of the company's common stock from time to time in open market, block, or privately negotiated transactions. The timing and extent of any repurchases will depend on market conditions, the trading price of the company's stock, and other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. The repurchase program may be modified or discontinued at any time without notice. The company intends to finance any stock repurchases through cash provided by operating activities.
####
About NVE Corporation
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. NVE has also licensed its spintronic magnetoresistive random access memory technology, commonly known as MRAM.
Statements used in this press release that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as risks in continued growth in revenue and profitability, risks associated with our reliance on several large customers, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
NVE CORPORATION STATEMENTS OF INCOME QUARTERS AND NINE MONTHS ENDED DECEMBER 31, 2008 AND 2007 (Unaudited) Quarter Ended December 31 2008 2007 ------------ ------------ Revenue Product sales $ 4,596,948 $ 4,249,809 Contract research and development 1,287,165 515,716 ------------ ------------ Total revenue 5,884,113 4,765,525 Cost of sales 1,763,090 1,663,045 ------------ ------------ Gross profit 4,121,023 3,102,480 Expenses Selling, general, and administrative 508,953 492,771 Research and development 258,998 347,344 ------------ ------------ Total expenses 767,951 840,115 ------------ ------------ Income from operations 3,353,072 2,262,365 Interest income 306,814 259,865 Other income 800 62,930 ------------ ------------ Income before taxes 3,660,686 2,585,160 Provision for income taxes 1,192,282 882,867 ------------ ------------ Net income $ 2,468,404 $ 1,702,293 ============ ============ Net income per share - basic $ 0.53 $ 0.37 ============ ============ Net income per share - diluted $ 0.52 $ 0.36 ============ ============ Weighted average shares outstanding Basic 4,665,333 4,637,275 Diluted 4,783,633 4,764,430 Supplemental financial data Stock-based compensation $ 5,598 $ 5,598 Cash paid for income taxes $ 1,175,000 $ 725,000 Nine Months Ended December 31 2008 2007 ------------ ------------ Revenue Product sales $ 14,015,651 $ 12,830,771 Contract research and development 2,460,038 1,648,657 ------------ ------------ Total revenue 16,475,689 14,479,428 Cost of sales 4,918,140 4,956,973 ------------ ------------ Gross profit 11,557,549 9,522,455 Expenses Selling, general, and administrative 1,623,810 1,631,936 Research and development 925,893 1,169,018 ------------ ------------ Total expenses 2,549,703 2,800,954 ------------ ------------ Income from operations 9,007,846 6,721,501 Interest income 838,323 731,243 Other income 4,200 62,930 ------------ ------------ Income before taxes 9,850,369 7,515,674 Provision for income taxes 3,178,968 2,581,272 ------------ ------------ Net income $ 6,671,401 $ 4,934,402 ============ ============ Net income per share - basic $ 1.43 $ 1.06 ============ ============ Net income per share - diluted $ 1.40 $ 1.04 ============ ============ Weighted average shares outstanding Basic 4,656,758 4,634,102 Diluted 4,774,925 4,761,112 Supplemental financial data Stock-based compensation $ 81,074 $ 164,008 Cash paid for income taxes $ 2,806,000 $ 2,209,313 NVE CORPORATION BALANCE SHEETS DECEMBER 31 AND MARCH 31, 2008 (Unaudited) Dec. 31, March 31, 2008 2008 ------------ ------------ ASSETS Current assets Cash and cash equivalents $ 2,438,109 $ 1,885,867 Marketable securities, short term 498,835 795,728 Accounts receivable, net of allowance for uncollectible accounts of $15,000 2,699,346 3,226,027 Inventories 2,462,098 2,456,804 Deferred tax assets 509,271 453,405 Prepaid expenses and other assets 614,516 529,616 ------------ ------------ Total current assets 9,222,175 9,347,447 Fixed assets Machinery and equipment 5,328,531 5,205,288 Leasehold improvements 450,546 436,794 ------------ ------------ 5,779,077 5,642,082 Less accumulated depreciation 4,356,826 4,276,680 ------------ ------------ Net fixed assets 1,422,251 1,365,402 Marketable securities, long term 29,179,003 22,055,279 ------------ ------------ Total assets $ 39,823,429 $ 32,768,128 ============ ============ LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable $ 405,815 $ 434,808 Accrued payroll and other 612,011 632,338 Deferred revenue 125,000 187,500 ------------ ------------ Total current liabilities 1,142,826 1,254,646 Shareholders' equity Common stock 46,653 46,387 Additional paid-in capital 19,100,787 18,539,538 Accumulated other comprehensive income 37,363 103,158 Retained earnings 19,495,800 12,824,399 ------------ ------------ Total shareholders' equity 38,680,603 31,513,482 ------------ ------------ Total liabilities and shareholders' equity $ 39,823,429 $ 32,768,128 ============ ============
For more information, please click here
Contacts:
NVE Corporation
Curt A. Reynders, CFO
(952) 829-9217
Copyright © GlobeNewswire, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Spintronics
Quantum materials: Electron spin measured for the first time June 9th, 2023
Spin photonics to move forward with new anapole probe November 4th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||